Ethane

Ethane

SCHEMBL7405342

CC.CN(CC(=O)O)c1ccccc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
NLRP3 Q96P20 1/20 0.47
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
ALDH1A1 P00352 2/20 0.45
RXFP1 Q9HBX9 1/20 0.45
GLA P06280 1/20 0.45
TSHR P16473 1/20 0.45
OPRM1 P35372 1/20 0.43
OPRL1 P41146 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196635 0.98 KMT2A (0.49) KMT2AMEN1NLRP3CA12CA2
Hydrochloric Acid SCHEMBL2238154 0.96 KMT2A (0.47) KMT2AMEN1NLRP3CA12CA2
SCHEMBL11973878 0.96 KMT2A (0.47) KMT2AMEN1NLRP3CA12CA2
SCHEMBL11973371 0.96 KMT2A (0.47) KMT2AMEN1NLRP3CA12CA2
SCHEMBL14067916 0.86 ALDH1A1 (0.53) ALDH1A1TSHRHTTSMN1; SMN2RAB9A
SCHEMBL1547824 0.84 KMT2A (0.49) KMT2AMEN1NLRP3CA12CA2
SCHEMBL9456006 0.81 FFAR1 (0.46) CA12CA2CA9ALDH1A1
Phenylglycine SCHEMBL7929007 0.81 RXFP1 (0.40) KMT2AMEN1NLRP3RXFP1
SCHEMBL29367590 0.81 OPRM1 (0.47) KMT2AMEN1NLRP3CA12CA2
SCHEMBL3348892 0.81 KEAP1 (0.54) KMT2ACA12CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed